SPARC Share has been steadily attracting investor attention due to its strong fundamentals and growth potential in the market. With consistent performance and strategic initiatives, the company is well-positioned to benefit from expanding opportunities in its sector.
Analysts are closely monitoring SPARC’s financial growth, operational efficiency, and market trends to project its share price in the coming years. The SPARC share price targets for 2026, 2027, 2028, 2029, and 2030 reflect a positive outlook for long-term investors seeking steady returns.
SPARC Share Price Target 2026
SPARC (Sun Pharma Advanced Research Company) continues to gain investor interest due to its strong focus on innovative drug development and a growing pipeline of specialty pharmaceutical products.
With strategic partnerships and ongoing clinical advancements, the company is expected to strengthen its revenue visibility in the coming years. Analysts believe that SPARC’s improved R&D efficiency and market expansion strategies could drive steady growth by 2026.
Based on current trends, the SPARC share price target for 2026 is expected to be around ₹160, while in a more bullish scenario, the second target could reach ₹170. This makes SPARC a promising stock to watch for long-term investors.
SPARC Share Price Target 2026 Table
| Year | SPARC Share Price Target 2026 |
| First Target 2026 | Rs 160 |
| Second Target 2026 | Rs 170 |
SPARC Share Price Target 2027
SPARC (Sun Pharma Advanced Research Company) continues to attract investor interest due to its strong focus on innovative drug development and a growing pipeline of specialty pharmaceutical products.
With its consistent R&D advancements and strategic collaborations, the company is well-positioned for long-term value creation. By 2027, analysts expect SPARC to deliver improved financial performance as new products reach commercialization stages.
Considering current trends and future growth potential, the SPARC share price target for 2027 is expected to be ₹180 on the lower side and ₹190 on the higher side. These targets reflect optimism about the company’s sustained progress in the pharma innovation space.
SPARC Share Price Target 2027 Table
| Year | SPARC Share Price Target 2027 |
| First Target 2027 | Rs 180 |
| Second Target 2027 | Rs 190 |
SPARC Share Price Target 2028
SPARC, a leading player in the healthcare and pharmaceutical sector, has been steadily expanding its presence through innovative products and strategic partnerships.
With a strong focus on research and development, the company is well-positioned to benefit from growing demand in both domestic and international markets. Analysts expect the SPARC share price target for 2028 to range between ₹200 and ₹220, reflecting its robust growth potential and consistent financial performance.
Investors are closely watching its strategic initiatives and expansion plans, which could drive long-term value creation. With a solid business model and a focus on sustainable growth, SPARC remains an attractive option for market participants seeking promising opportunities.
SPARC Share Price Target 2028 Table
| Year | SPARC Share Price Target 2028 |
| First Target 2028 | Rs 200 |
| Second Target 2028 | Rs 220 |
SPARC Share Price Target 2029
SPARC Limited, a prominent player in the infrastructure and real estate sector, is steadily gaining investor attention due to its strong project portfolio and consistent performance.
With strategic expansions and a focus on sustainable growth, the company is well-positioned to capitalize on India’s growing urban development trends.
Analysts predict that the SPARC share price target for 2029 could range between ₹240 and ₹250, reflecting potential long-term growth. Strong fundamentals, robust project execution, and increasing demand in the real estate market make SPARC an attractive option for investors looking ahead.
| Year | SPARC Share Price Target 2029 |
| First Target 2029 | Rs 240 |
| Second Target 2029 | Rs 250 |
SPARC Share Price Target 2030
SPARC, a leading player in the pharmaceutical and biotechnology sector, continues to attract strong investor interest due to its consistent growth and robust product pipeline.
With increasing demand for innovative healthcare solutions and a focus on research-driven development, the company is well-positioned to capitalize on both domestic and international markets.
Analysts project that the SPARC share price target for 2030 could reach between ₹2,800 and ₹3,200, reflecting its strong growth potential and sustainable performance. With strategic expansions and continuous innovation, SPARC is expected to maintain steady momentum, making it an appealing option for long-term investors.
SPARC Share Price Target 2030 Table
| Year | SPARC Share Price Target 2030 |
| First Target 2030 | Rs 260 |
| Second Target 2030 | Rs 280 |
SPARC Share F.A.Q.
– Does SPARC pay dividends?
Yes, SPARC may distribute dividends depending on its annual profits and board decisions.
– What influences SPARC’s share price?
The share price is influenced by market trends, company performance, and investor sentiment.
– Where can I track SPARC Share performance?
You can track SPARC shares on stock exchange websites or financial news platforms.
Conclusion
Overall, SPARC Share presents an encouraging growth story, supported by its robust business model and market positioning. Investors looking for medium- to long-term opportunities may find these price targets insightful for planning their investment strategies. While market fluctuations are inevitable, SPARC’s consistent performance and expansion plans suggest a promising trajectory for its share price from 2026 through 2030.
Also read:-